Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860534 · ClinicalTrials.gov registry record · NA
"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
A NA study of Light Sensitivity, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01860534 is a NA study of Light Sensitivity that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01860534, a NA study of Light Sensitivity, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Pupillary dilation induced by mydriatic agents during Retinopathy of Prematurity exams can persist for hours. Despite regular use of eye protection for mydriatic-induced light sensitivity for infants, children and adults, eye protection after mydriasis has not been addressed in neonates. This study examines the use of eye patches to protect the dilated pupil from light exposure and their impact on vital signs and pain scores. prevents tachycardia, tachypnea and discomfort in neonates after ROP screening.
Conditions Studied
Interventions
- BEHAVIORAL eye covers
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860534
The ClinicalTrials.gov registry entry for NCT01860534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Light Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which eye covers is the first listed.
NCT01860534 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01860534 about?
NCT01860534 is a clinical study titled ""Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"". Pupillary dilation induced by mydriatic agents during Retinopathy of Prematurity exams can persist for hours. Despite regular use of eye protection for mydriatic-induced light sensitivity for infants, children and adults, eye protection after mydriasis has not been addressed in neonates. This study ...
What is the current status of trial NCT01860534?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2011-07. Estimated completion is 2012-09.
What conditions does trial NCT01860534 study?
This clinical trial studies the following conditions: Light Sensitivity.
What interventions are being tested in trial NCT01860534?
The interventions under investigation include: eye covers (BEHAVIORAL).
Who is sponsoring clinical trial NCT01860534?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01860534 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.